Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jara, L.J.
Right arrow Articles by Espinoza, L.R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jara, L.J.
Right arrow Articles by Espinoza, L.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 6, No. 3, 258-260 (1997)
DOI: 10.1177/096120339700600308

Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patients

L.J. Jara

Rheumatology Department, Hospital de Especialidades, Centro Medico La Raza, IMSS, Mexico D.F., Mexico

C. Prasad

Sections of Rheumatology and Endocrinology, Department of Medicine, Louisiana State University Medical Center, 1542 Tulane Ave., New Orleans, LA 70112-2822, USA

L.R. Espinoza

Sections of Rheumatology and Endocrinology, Department of Medicine, Louisiana State University Medical Center, 1542 Tulane Ave., New Orleans, LA 70112-2822, USA

Cyclo (His-Pro) or CHP is a cyclic dipeptide that is known to elicit many biologic activities including inhibition of pituitary prolactin (PRL) secretion. PRL stimulates humoral and cell mediated immune responses and hyperprolactinemia has been found in a subset of systemic lupus erythematosus (SLE) patients in association with active disease. To explore whether CHP may play a role in SLE patients, we measured, CHP and PRL levels in sera of 21 SLE patients and 11 normal controls. The results of this study show significantly (P < 0.001) high levels of CHP in SLE compared to controls. However, there was no significant correlation between serum PRL and CHP levels in SLE patients (r = 0.027, P = 0.29). The increase in serum levels of CHP may be in an attempt to increase hypothalamic content of dopamine which in turn would decrease pituitary PRL synthesis in hyperprolactinemic SLE patients.

Key Words: cyclo (His-Pro) • prolactin • neuropeptides • SLE


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
I Mendez, J Alcocer-Varela, A Parra, A Lava-Zavala, D A de la Cruz, D Alarcon-Segovia, and F Larrea
Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin
Lupus, January 1, 2004; 13(1): 45 - 53.
[Abstract] [PDF]

Home page
 LupusHome page
L J Jara, O Vera-Lastra, J M Miranda, M Alcala, and J Alvarez-Nemegyci
Prolactin in human systemic lupus erythematosus
Lupus, October 1, 2001; 10(10): 748 - 756.
[Abstract] [PDF]

Home page
 LupusHome page
C Ferreira, M Paes, A Gouveia, E Ferreira, F Padua, and T Fiuaza
Plasma homovanillic acid and prolactin in systemic lupus erythematosus
Lupus, July 1, 1998; 7(6): 392 - 397.
[Abstract] [PDF]